Canada Markets closed

Emergent Health Corp (EMGE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0048-0.0003 (-5.88%)
At close: 12:58PM EST

Emergent Health Corp

10120 Valley Forge Circle
Suite 257
King of Prussia, PA 19406
United States

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees6

Key Executives

NameTitlePayExercisedYear Born
Mr. James W. ZimblerChief Exec. OfficerN/AN/A1966
Mr. Gregory McCauleyCorp. CounselN/AN/AN/A
Mr. Marvin SegelDirector & CMON/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.

Corporate Governance

Emergent Health Corp’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.